Drozitumab
Appearance
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | DR5 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6334H9792N1700O2000S42 |
Molar mass | 143.1 kg/mol g·mol−1 |
(what is this?) (verify) |
Drozitumab is a human monoclonal antibody designed for the treatment of cancers.[1]
Drozitumab was developed by Genentech.
Adverse drug effects
This section is empty. You can help by adding to it. (October 2014) |
References